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Renal Function Assessment is Part of Endovascular Aortic Aneurysm 
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Endovascular aneurysm repair (EVAR) is the preferred approach 
for treatment of abdominal aortic aneurysm (AAA) when 
anatomy is compatible. Early and medium term morbidity and 
mortality rates are lower with EVAR than open aortic repair 
(OAR). In the long term EVAR is however associated with 
higher reinterventions rate and lower survival [1]. 
Acute kidney injury (AKI) is a common complication after both 
EVAR and OAR [2]. Based on the Acute Kidney Injury Network 
(AKIN) and Risk, Injury, Failure, Loss, End-stage (RIFLE) 
staging systems, AKI is defined as increase in serum creatinine 
by ≥ 0,3 mg/dl within 48 hours, or increase in serum creatinine to 
≥ 1,5 times baseline within 7 days, or urine output < 0,5 ml/kg/h 
for 6 hours [3]. The mechanisms of renal damage after EVAR are 
multiple : contrast induced nephropathy, renal micro-
embolization secondary to intra-aortic navigation or device 
deployment, coverage of accessory renal artery, iatrogenic renal 
artery dissection,  ischemia reperfusion syndrome due to lower 
limb ischemia, hypovolemia, aneurysmal sac inflammatory 
infiltrate and patient related cardiovascular comorbidities and 
treatment [4]. 
The incidence of AKI after EVAR varies from 5 to 18% [2,4]. In 
the prospective study of Saratzis et al. [4], AKI is more prevalent 
in patients with impaired renal function and 
hypercholesterolemia. In the Midlands Aortic Renal Injury 
(MARI) cohort study, age, history of ischaemic heart disease and 
baseline estimated glomerular filtration rate (eGFR) are 
predictors of AKI for patients undergoing EVAR [5]. Statius van 
Eps et al reported in their retrospective study [6] that use of 
angiotensin II blockers and peri-operative complications are risk 
factors for AKI after EVAR. Both impaired renal function before 
EVAR and AKI are associated with cardiovascular morbidity and 
mortality.   
Long term renal function decreases after EVAR. Charles et al 
reported in their 9 years follow up study yearly drop of eGFR of 
1.7 ml/min/1.73m² [7]. The decline seems to be steeper the first 
year after EVAR [8]. This is associated with lower survival. Age, 
male sex, diabetes and prior history of ischaemic heart disease 
are associated with eGFR drop of more than 20% 9 years after 
EVAR in the study of Charles et al [7]. Statius van Eps et al 
identified aortic neck diameter, renal artery stenosis > 50% and 
AKI as risk factors for occurrence of chronic kidney disease after 
EVAR [6].  
AKI and long term renal function decline are common after 
EVAR and associated with cardiovascular morbidity and 
mortality. We have to think about it when young patients are 
candidate for EVAR. Serum creatinine and urine output have to 
be checked in EVAR peri-operative period. Measurement of 
eGFR before treatment and during follow up is needed. It will 
allow the physicians to reinforce renal protective therapies and to 
send as early as possible patients to nephrologists [9]. Risk 
factors for AKI and long term renal function decline after EVAR 
have to be confirmed. Potential new diagnostic markers, 
prevention modalities and therapeutic agents have to be evaluated 
and validated in prospective studies. 
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